Modification of experimental myocardial infarct size by cardiac drugs.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002306:Cardiac Volume / Q000187:drug effects; D003326:Coronary Circulation; D003331:Coronary Vessels; D004195:Disease Models, Animal; D004285:Dogs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000627:therapeutic use*; D008729:Methoxamine / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy*; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000627:therapeutic use*; D010042:Ouabain / Q000627:therapeutic use*; D010101:Oxygen Consumption / Q000187:drug effects
D010042:Ouabain; D008729:Methoxamine; D007545:Isoproterenol; D009638:Norepinephrine